Cargando…
Monitoring tacrolimus toxicity following Paxlovid administration in a liver transplant patient
Maintaining therapeutic plasma tacrolimus concentrations is essential for mitigating potential solid organ transplant rejection and preventing toxic adverse side effects. While patients can benefit greatly from tacrolimus therapy, co-administration of drugs such as Paxlovid (nirmatrelvir/ritonavir)...
Autores principales: | Maynard, Robert D., Bates, Phillip, Korpi-Steiner, Nichole |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10462658/ https://www.ncbi.nlm.nih.gov/pubmed/37649541 http://dx.doi.org/10.1016/j.plabm.2023.e00322 |
Ejemplares similares
-
Paxlovid with Caution: Novel Case of Paxlovid-Induced Tacrolimus Toxicity in a Cardiac Transplant Patient
por: Shah, Aaisha, et al.
Publicado: (2022) -
Case Report: tacrolimus toxicity in the setting of concurrent Paxlovid use in a heart-transplant recipient
por: Modi, Sujal, et al.
Publicado: (2023) -
Treatment of acute tacrolimus toxicity with phenytoin after Paxlovid (nirmatrelvir/ritonavir) administration in a kidney transplant recipient
por: Kwon, Eun-Jeong, et al.
Publicado: (2022) -
Tacrolimus Drug–Drug Interaction with Nirmatrelvir/Ritonavir (Paxlovid™) Managed with Phenytoin
por: Sindelar, Morganne, et al.
Publicado: (2022) -
Paxlovid-Induced Tacrolimus Toxicity in the Treatment of COVID-19: A Case Report
por: Michael, Stephanie, et al.
Publicado: (2023)